Table 2.
Ref. | Year | Population | Comparison | miRNA | Outcome | Methodology |
---|---|---|---|---|---|---|
Besler et al. [44] | 2016 | 76 VMC pts | 22 DCM pts | miR-133a miR-155 |
↑ miR-133a, miR-155 in MC pts ↑ miR-133a associated with ↓ fibrosis and ↑ LV function miR-133a and miR-155 levels correlated with inflammatory cells count in MC pts |
miRs in heart tissue by qPCR fibrosis, inflammatory cells by HP LV function in ECHO |
Ferreira et al. [45] | 2014 | 10 CCC pts | 6 DCM pts 4 HCs |
miR-1 miR-133a miR-133b miR-208a miR-208b |
↓ miR-1, miR-133a and miR-208b in CCC pts compared to others ↓ miR-133b and miR-208a in CCC pts compared to HCs |
miRs in heart tissue by qPCR |
Bao et al. [46] | 2014 | 6 acute MC pts | 6 HCs | miR-155 miR-148a |
↑ miR-155 and miR-148a in MC pts | miRs in heart biopsy by qPCR |
Chen et al. [47] | 2015 | 8 acute VMC pts | 8 HCs | miR-214 miR-146b |
↓ miR-214 and miR-146b in VMC pts | miRs in heart tissue by qPCR |
Kühl et al. [48] | 2012 | 15 active B19V infection pts | 45 inactive B19V infection pts | miRNAome | 29 differently-expressed miRs predicted miR-Ts involved in immune response and energy metabolism |
miRs in heart tissue by qPCR |
Corsten et al. [37] | 2012 | 4 acute MC pts | 6 HCs | miRNAome | 107 deregulated miRs in MC pts compared to HCs | miRs in heart biopsy by microarray analysis |
↑—increased, ↓—decreased, B19V—Parvovirus B19, CCC—chronic Chagas disease cardiomyopathy, DCM—dilated cardiomyopathy, ECHO—echocardiography, HCs—healthy controls, HP—histopathology, LV—left ventricle, MC—myocarditis, miR/miRNA—microRNA, miR-Ts—miRNA target sequences, pts—patients, qPCR—quantitative polymerase chain reaction, ref.—reference, RNA—ribonucleic acid, VMC—viral myocarditis.